1. Home
  2. CVAC vs MSIF Comparison

CVAC vs MSIF Comparison

Compare CVAC & MSIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • MSIF
  • Stock Information
  • Founded
  • CVAC 2000
  • MSIF 2011
  • Country
  • CVAC Germany
  • MSIF United States
  • Employees
  • CVAC N/A
  • MSIF N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • MSIF
  • Sector
  • CVAC Health Care
  • MSIF
  • Exchange
  • CVAC Nasdaq
  • MSIF NYSE
  • Market Cap
  • CVAC 818.8M
  • MSIF 791.6M
  • IPO Year
  • CVAC 2020
  • MSIF N/A
  • Fundamental
  • Price
  • CVAC $3.12
  • MSIF $15.83
  • Analyst Decision
  • CVAC Buy
  • MSIF Buy
  • Analyst Count
  • CVAC 2
  • MSIF 4
  • Target Price
  • CVAC $10.00
  • MSIF $18.75
  • AVG Volume (30 Days)
  • CVAC 717.4K
  • MSIF 74.8K
  • Earning Date
  • CVAC 04-10-2025
  • MSIF 01-01-0001
  • Dividend Yield
  • CVAC N/A
  • MSIF 2.32%
  • EPS Growth
  • CVAC N/A
  • MSIF N/A
  • EPS
  • CVAC 0.75
  • MSIF 1.41
  • Revenue
  • CVAC $554,073,921.00
  • MSIF $134,828,000.00
  • Revenue This Year
  • CVAC N/A
  • MSIF $6.72
  • Revenue Next Year
  • CVAC $66.34
  • MSIF $12.18
  • P/E Ratio
  • CVAC $4.19
  • MSIF $11.25
  • Revenue Growth
  • CVAC 895.54
  • MSIF 2.62
  • 52 Week Low
  • CVAC $2.22
  • MSIF $14.01
  • 52 Week High
  • CVAC $5.28
  • MSIF $18.00
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 53.48
  • MSIF N/A
  • Support Level
  • CVAC $3.05
  • MSIF N/A
  • Resistance Level
  • CVAC $3.02
  • MSIF N/A
  • Average True Range (ATR)
  • CVAC 0.19
  • MSIF 0.00
  • MACD
  • CVAC 0.06
  • MSIF 0.00
  • Stochastic Oscillator
  • CVAC 79.14
  • MSIF 0.00

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About MSIF MSC INCOME FUND INC

MSC Income Fund Inc is a non-diversified closed-end management investment company. The investment objective is to generate current income through debt and equity investments and the secondary objective is to generate long-term capital appreciation through such investments. The company invests in senior secured term loans, second lien loans, and mezzanine debt and selected equity investments issued by lower middle-market and middle-market companies.

Share on Social Networks: